Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
111,633,839
-
Total 13F shares
-
77,188,491
-
Share change
-
-616,520
-
Total reported value
-
$613,226,946
-
Put/Call ratio
-
27%
-
Price per share
-
$7.95
-
Number of holders
-
169
-
Value change
-
-$47,944,387
-
Number of buys
-
107
-
Number of sells
-
65
Institutional Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q2 2019
As of 30 Jun 2019,
Evolent Health, Inc. - Class A Common Stock (EVH) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,188,491 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, RIVERBRIDGE PARTNERS LLC, CREDIT SUISSE AG/, GLENMEDE TRUST CO NA, Bellevue Group AG, Standard Life Aberdeen plc, and Elk Creek Partners, LLC.
This page lists
169
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.